Unchecked, the liver develops cirrhosis
It sends signals to your brain to say, Im full now. In short, GLP-1 is part of the bodys natural appetite and sugar control system
Moreover, GLP-1 has shown direct effects on diabetic CVD aspects including endothelial dysfunction, inflammation, angiogenesis, and cardiac remodeling
Since ADA (American Diabetes Association) and FDA confirmed that apart from metformin in Type 2 diabetes management, Glucagon-like peptide-1 analogues give favourable results, especially in contraindication and metformin intolerance patients, so the use of GLP-1 agonists is highly preferred treatment in lower serum glucose levels or hypoglycemia
More than 42% of adults under 65 with private insurance could be eligible for these medications under current FDA guidelines